Stock Details
MCK is McKesson Corporation's stock. Stock exchange NYSE (Currency USD). Average price in 50 days is 320.32$. Average daily volumn in 3 months 1.2M. Market cap 46.76B



Stock symbol : MCK. Exchange : NYSE. Currency : USD
Lastest price : 323.85$. Total volume : 268.79k. Market state REGULAR
Click reload if you want to check the lastest price on market!!!

McKesson Corporation (MCK)
Last Price
323.85$
Change
-2.36
Volume
268.79k

Previous Close326.21
Open325.70
Day Range320.64-328.07
Bid322.36 x 1.1k
Ask322.69 x 1.2k
Volume268.79k
Average Volume1.2M
Market Cap46.76B
Beta0.66
52 Week Range186.61-339.94
Trailing P/E44.61
Foward P/E12.70
Dividend (Yield %)0.58%
Ex-Dividend Date2022-05-31



Financial Details


According to McKesson Corporation's financial reports the company's revenue in 2022 were 263.97B an increase( +10.5%) over the years 2021 revenue that were of 238.23B. In 2022 the company's total earnings were 1.11B while total earnings in 2021 were -4.54B(-125%).


Loading ...



Organization

McKesson Corporation provides healthcare services in the United States and internationally. It operates through four segments: U.S. Pharmaceutical, International, Medical-Surgical Solutions, and Prescription Technology Solutions (RxTS). The U.S. Pharmaceutical segment distributes branded, generic, specialty, biosimilar, and over-the-counter pharmaceutical drugs and other healthcare-related products. This segment also provides practice management, technology, clinical support, and business soluti... ons to community-based oncology and other specialty practices; and consulting, outsourcing, technological, and other services, as well as sells financial, operational, and clinical solutions to pharmacies. The International segment offers distribution and services to wholesale, institutional, and retail customers in 13 European countries and Canada. The Medical-Surgical Solutions segment provides medical-surgical supply distribution, logistics, and other services to healthcare providers. The RxTS segment serves biopharma and life sciences partners and patients to address medication challenges for patients throughout their journeys; connects pharmacies, providers, payers, and biopharma companies to deliver innovative access and adherence solutions; and provides third-party logistics and wholesale distribution support solutions. McKesson Corporation was founded in 1833 and is headquartered in Irving, Texas.

Market Cap:
46.76B
Revenue:
263.97B
Total Assets:
63.3B
Total Cash:
3.53B


News about "McKesson Corporation"

McKesson (MCK) Stock Moves -0.56%: What You Should Know

Source from : Nasdaq - 1 days ago

McKesson (MCK) closed the most recent trading day at $326.21, moving -0.56% from the previous trading session. This change was narrower than the S&P 500's 0.88% loss on the day. At the same time, the ...See details»


McKesson Corporation Announces First Quarter Fiscal 2023 Earnings Release Date

Source from : Associated Press - 2 days ago

McKesson Corporation (NYSE: MCK) will release its first quarter fiscal 2023 financial results after market close on Wednesday, August 3, 2022. The company will host a live webcast of the earnings ...See details»


mckessons-mck-latest-jv-to-boost-cancer-treatment-options-image

McKesson's (MCK) Latest JV to Boost Cancer Treatment Options

Source from : YAHOO!Finance - 7 days ago

The JV will combine McKessonโ€™s US Oncology Research (โ€œUSORโ€) and HCA Healthcareโ€™s Sarah Cannon Research Institute (โ€œSCRIโ€). Following the completion of the deal, which is expected to close in 2022, ...See details»


wealthcare-advisory-partners-llc-takes-position-in-mckesson-co-nysemck-image

Wealthcare Advisory Partners LLC Takes Position in McKesson Co. (NYSE:MCK)

Source from : Defense World - 1 days ago

Wealthcare Advisory Partners LLC bought a new stake in shares of McKesson Co. (NYSE:MCK โ€“ Get Rating) during the 1st quarter, HoldingsChannel reports. The institutional investor bought 885 shares of ...See details»


mckesson-best-of-breed-in-drug-distributor-oligopoly-image

McKesson: Best Of Breed In Drug Distributor Oligopoly

Source from : Seeking Alpha - 11 days ago

McKesson's value proposition is best of breed in the healthcare distributor oligopoly. Read why investors should take a deeper look at this stock.See details»


its-official-hca-announces-sarah-cannon-joint-venture-with-mckesson-image

It's official: HCA announces Sarah Cannon joint venture with McKesson

Source from : The Business Journals - 8 days ago

HCA Healthcare Inc. and McKesson Corporation are joining their oncology research forces to form a new joint venture ...See details»


ritholtz-wealth-management-takes-394000-position-in-mckesson-co-nysemck-image

Ritholtz Wealth Management Takes $394,000 Position in McKesson Co. (NYSE:MCK)

Source from : Defense World - 2 days ago

Ritholtz Wealth Management acquired a new stake in McKesson Co. (NYSE:MCK โ€“ Get Rating) during the 1st quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission ...See details»


hca-healthcare-hca-boosts-cancer-portfolio-with-mckesson-jv-image

HCA Healthcare (HCA) Boosts Cancer Portfolio With McKesson JV

Source from : YAHOO!Finance - 3 days ago

HCA Healthcare (HCA) inks a joint venture with McKesson to strengthen the cancer offerings suite of both partners. The move will offer HCA the chance to capitalize on the growing cancer therapeutics ...See details»


The Oncology Institute Announces Expanded Strategic Agreement with McKesson for Distribution of Pharmaceuticals

Source from : Associated Press - 4 days ago

The Oncology Institute, Inc. (NASDAQ: TOI) (โ€œTOIโ€ or the โ€œCompanyโ€), one of the largest value-based oncology groups in the United States, announced today the signing of an expanded partnership ...See details»


mckesson-hca-healthcare-to-form-jv-for-cancer-research-image

McKesson, HCA Healthcare To Form JV For Cancer Research

Source from : Nasdaq - 8 days ago

McKesson Corporation (MCK) and HCA Healthcare, Inc. (HCA), said on Thursday that they have inked a deal to form a joint venture by combining McKesson's US Oncology Research or USOR and HCA ...See details»


insider-selling-mckesson-co-nysemck-ceo-sells-4767-shares-of-stock-image

Insider Selling: McKesson Co. (NYSE:MCK) CEO Sells 4,767 Shares of Stock

Source from : ETF Daily News - 14 days ago

Institutional investors own 85.45% of the companyโ€™s stock. McKesson Company Profile (Get Rating) McKesson Corporation provides healthcare supply chain management, retail pharmacy, community oncology ...See details»


moody-national-bank-trust-division-has-107-million-holdings-in-mckesson-co-nysemck-image

Moody National Bank Trust Division Has $1.07 Million Holdings in McKesson Co. (NYSE:MCK)

Source from : ETF Daily News - 7 days ago

0.21% of the stock is owned by insiders. About McKesson (Get Rating) McKesson Corporation provides healthcare supply chain management, retail pharmacy, community oncology and specialty care, and ...See details»


health-care-giants-mckesson-and-hca-partner-up-in-cancer-research-joint-venture-image

Health care giants McKesson and HCA partner up in cancer research joint venture

Source from : Dallas Morning News - 8 days ago

Two big names in health care are joining forces to expand clinical cancer research. Irving-based McKesson Corp. and HCA Healthcare, parent company of the Medical City hospitals in Dallas-Fort Worth, ...See details»


New Suit - Class Action

Source from : Law - 10 days ago

Counsel have not yet appeared for the defendant. The case is 1:22-cv-00927, Iskhakova v. McKesson Corporation.See details»